• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AR 依赖性细胞周期:机制与癌症相关性。

The AR dependent cell cycle: mechanisms and cancer relevance.

机构信息

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12.

DOI:10.1016/j.mce.2011.06.033
PMID:21782001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3641823/
Abstract

Prostate cancer cells are exquisitely dependent on androgen receptor (AR) activity for proliferation and survival. As these functions are critical targets of therapeutic intervention for human disease, it is imperative to delineate the mechanisms by which AR engages the cell cycle engine. More than a decade of research has revealed that elegant intercommunication between AR and the cell cycle machinery governs receptor-dependent cellular proliferation, and that perturbations in this process occur frequently in human disease. Here, AR-cell cycle interplay and associated cancer relevance will be reviewed.

摘要

前列腺癌细胞的增殖和存活对雄激素受体 (AR) 的活性具有高度依赖性。由于这些功能是人类疾病治疗干预的关键靶点,因此必须阐明 AR 与细胞周期引擎相互作用的机制。十多年的研究表明,AR 与细胞周期机制之间的精细相互通讯控制着受体依赖性细胞增殖,并且该过程中的干扰在人类疾病中经常发生。在这里,将回顾 AR-细胞周期相互作用及其与癌症的相关性。

相似文献

1
The AR dependent cell cycle: mechanisms and cancer relevance.AR 依赖性细胞周期:机制与癌症相关性。
Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12.
2
AR, the cell cycle, and prostate cancer.雄激素受体、细胞周期与前列腺癌
Nucl Recept Signal. 2008 Feb 1;6:e001. doi: 10.1621/nrs.06001.
3
Role of androgen receptor in prostate cancer cell cycle regulation: interaction with cell cycle regulatory proteins and enzymes of DNA synthesis.雄激素受体在前列腺癌细胞周期调控中的作用:与细胞周期调控蛋白和 DNA 合成酶的相互作用。
Curr Protein Pept Sci. 2010 Sep;11(6):451-8. doi: 10.2174/138920310791824075.
4
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.雄激素受体作为雄激素敏感性前列腺癌细胞中DNA复制的许可因子。
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15085-90. doi: 10.1073/pnas.0603057103. Epub 2006 Oct 2.
5
A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.钙/钙调蛋白依赖性蛋白激酶激酶 2(CaMKK2)与雄激素受体在前列腺癌进展中的调控反馈回路。
J Biol Chem. 2012 Jul 13;287(29):24832-43. doi: 10.1074/jbc.M112.370783. Epub 2012 May 31.
6
Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.雄激素受体在人类前列腺肿瘤细胞向雄激素非依赖性和不敏感性进展中的作用。
Prostate. 2005 Dec 1;65(4):287-98. doi: 10.1002/pros.20285.
7
Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.通过高通量成像进行雄激素受体功能分析:配体、细胞周期及突变特异性效应的测定
PLoS One. 2008;3(11):e3605. doi: 10.1371/journal.pone.0003605. Epub 2008 Nov 3.
8
BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.BAF57通过SWI/SNF调控雄激素受体作用及雄激素依赖性增殖。
Mol Cell Biol. 2005 Mar;25(6):2200-15. doi: 10.1128/MCB.25.6.2200-2215.2005.
9
An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.一条用于雄激素依赖性前列腺癌细胞增殖的AR-Skp2信号通路。
J Cell Sci. 2008 Aug 1;121(Pt 15):2578-87. doi: 10.1242/jcs.030742. Epub 2008 Jul 15.
10
Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.布雷非德菌素 A 通过靶向细胞周期和雄激素受体抑制雄激素反应性前列腺癌细胞的生长。
J Biomed Sci. 2010 Jan 26;17(1):5. doi: 10.1186/1423-0127-17-5.

引用本文的文献

1
Androgen Receptor Expression Governs the Seasonal Inhibition of Testicular Development and Subsequent Recovery in .雄激素受体表达调控睾丸发育的季节性抑制及随后的恢复。
Biology (Basel). 2025 Jan 24;14(2):123. doi: 10.3390/biology14020123.
2
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.雄激素受体(AR)与Yes相关蛋白(YAP)的相互作用:对前列腺癌治疗策略的影响
Front Oncol. 2025 Feb 3;15:1520808. doi: 10.3389/fonc.2025.1520808. eCollection 2025.
3
Post-eclosion growth in the Drosophila ejaculatory duct is driven by Juvenile hormone signaling and is essential for male fertility.果蝇射精管羽化后的生长由保幼激素信号驱动,对雄性生育能力至关重要。
Dev Biol. 2025 Mar;519:122-141. doi: 10.1016/j.ydbio.2024.12.010. Epub 2024 Dec 22.
4
Hormones as a double-edged sword: the role of hormones in cancer progression and the potential of targeted hormone therapies.激素犹如双刃剑:激素在癌症进展中的作用和靶向激素治疗的潜力。
Med Oncol. 2024 Oct 14;41(11):283. doi: 10.1007/s12032-024-02517-z.
5
Post-eclosion growth in the Ejaculatory Duct is driven by Juvenile Hormone signaling and is essential for male fertility.射精管羽化后的生长由保幼激素信号驱动,对雄性生育力至关重要。
bioRxiv. 2024 Aug 13:2024.08.12.607650. doi: 10.1101/2024.08.12.607650.
6
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium.前列腺癌雄激素受体研究的新兴前沿领域:第二届国际雄激素受体研讨会的见解
J Exp Clin Cancer Res. 2024 Jul 17;43(1):194. doi: 10.1186/s13046-024-03125-5.
7
A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance.前列腺癌治疗的新视角:细胞衰老与治疗抵抗之间的相互作用。
Front Immunol. 2024 Apr 17;15:1395047. doi: 10.3389/fimmu.2024.1395047. eCollection 2024.
8
Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer.转移性去势敏感前列腺癌的现行全身治疗。
Curr Oncol Rep. 2024 May;26(5):488-495. doi: 10.1007/s11912-024-01509-6. Epub 2024 Apr 9.
9
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium.前列腺癌中雄激素受体的新进展:第 1 届国际雄激素受体研讨会报告。
J Transl Med. 2024 Jan 18;22(1):71. doi: 10.1186/s12967-024-04878-5.
10
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.超生理剂量雄激素通过抑制 cMYC 并募集 DREAM 复合物来促进雄激素受体的肿瘤抑制活性。
Cancer Res. 2023 Sep 1;83(17):2938-2951. doi: 10.1158/0008-5472.CAN-22-2613.

本文引用的文献

1
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.SMAD4 依赖性屏障限制前列腺癌生长和转移进展。
Nature. 2011 Feb 10;470(7333):269-73. doi: 10.1038/nature09677. Epub 2011 Feb 2.
2
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.细胞周期蛋白 D1 是雄激素依赖性信号和雄激素受体功能的选择性修饰物。
J Biol Chem. 2011 Mar 11;286(10):8117-8127. doi: 10.1074/jbc.M110.170720. Epub 2011 Jan 5.
3
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo.E2f 结合缺陷型 Rb1 蛋白抑制体内前列腺肿瘤的进展。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):704-9. doi: 10.1073/pnas.1015027108. Epub 2010 Dec 27.
4
Towards a knowledge-based Human Protein Atlas.迈向基于知识的人类蛋白质图谱。
Nat Biotechnol. 2010 Dec;28(12):1248-50. doi: 10.1038/nbt1210-1248.
5
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.视网膜母细胞瘤肿瘤抑制因子控制雄激素信号和人前列腺癌的进展。
J Clin Invest. 2010 Dec;120(12):4478-92. doi: 10.1172/JCI44239. Epub 2010 Nov 22.
6
Phase III data for abiraterone in an evolving landscape for castration-resistant prostate cancer.阿比特龙在不断演变的去势抵抗性前列腺癌治疗格局中的 III 期数据。
Maturitas. 2011 Feb;68(2):103-5. doi: 10.1016/j.maturitas.2010.10.009. Epub 2010 Nov 19.
7
CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.细胞周期蛋白依赖性激酶9通过丝氨酸81磷酸化调节雄激素受体启动子选择性和细胞生长。
Mol Endocrinol. 2010 Dec;24(12):2267-80. doi: 10.1210/me.2010-0238. Epub 2010 Oct 27.
8
Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.雄激素通过视网膜母细胞瘤 (RB) 和 p130 依赖性途径抑制 EZH2 的表达:前列腺癌雄激素难治性进展的潜在机制。
Endocrinology. 2010 Nov;151(11):5136-45. doi: 10.1210/en.2010-0436. Epub 2010 Sep 29.
9
Integrative genomic profiling of human prostate cancer.人类前列腺癌的综合基因组分析。
Cancer Cell. 2010 Jul 13;18(1):11-22. doi: 10.1016/j.ccr.2010.05.026. Epub 2010 Jun 24.
10
Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.鉴定 ASF/SF2 为 cyclin D1b 癌基因的关键、等位基因特异性效应子。
Cancer Res. 2010 May 15;70(10):3975-84. doi: 10.1158/0008-5472.CAN-09-3468. Epub 2010 May 11.